Literature DB >> 25123160

The use of endoscopic cyclophotocoagulation for moderate to advanced glaucoma.

Kevin Kaplowitz1, Andrew Kuei1, Britany Klenofsky1, Azin Abazari1, Robert Honkanen1.   

Abstract

Endoscopic Cyclophotocoagulation (ECP) is a glaucoma surgery designed to reduce the intraocular pressure (IOP) by partially ablating the ciliary processes to decrease aqueous humour production and secretion. The aim of this paper is to review the literature regarding the background, indications and results of the surgery. Although there are case reports of visually devastating complications, including persistent hypotony and phthisis, the use of ECP is often reported in eyes with advanced diseases. When compared with both trabeculectomy and aqueous shunt implantation, the visual outcomes were better with ECP while the IOP outcomes were very similar. The evidence supports ECP as a very effective surgical option in recalcitrant glaucoma while some evidence supports its safety for use as a primary procedure.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diode; endoscopic cyclophotocoagulation; glaucoma; laser; transscleral

Mesh:

Year:  2014        PMID: 25123160     DOI: 10.1111/aos.12529

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  10 in total

1.  Argon laser-assisted hypotony model in the rabbit.

Authors:  Gokhan Gurelik; Sabahattin Sul; Pınar Uyar Gocun; Safak Korkmaz; Cemal Ozsaygili
Journal:  Lasers Med Sci       Date:  2018-06-29       Impact factor: 3.161

Review 2.  Endoscopy-assisted vitrectomy in the anterior vitreous.

Authors:  Yong-Zhen Yu; Yu-Ping Zou; Xiu-Lan Zou
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

3.  Transpupillary Argon Laser Cyclophotocoagulation in a Refractory Traumatic Glaucoma Patient with Aphakia and Aniridia.

Authors:  Umut Duygu Uzunel; Berna Yüce; Tuncay Küsbeci; Halil Ateş
Journal:  Turk J Ophthalmol       Date:  2016-01-05

4.  Development of a biodegradable antifibrotic local drug delivery system for glaucoma microstents.

Authors:  Thomas Stahnke; Stefan Siewert; Thomas Reske; Wolfram Schmidt; Klaus-Peter Schmitz; Niels Grabow; Rudolf F Guthoff; Andreas Wree
Journal:  Biosci Rep       Date:  2018-08-31       Impact factor: 3.840

5.  Does prior endoscopic cyclophotocoagulation (ECP) affect subsequent trabeculectomy outcomes?

Authors:  Abhijit Anand Mohite; Emma Samia-Aly; Uthaya Shankar Ramanathan; Patrick G Corridan; Shashidhar Murthy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-25       Impact factor: 3.535

6.  Long-term Surgical Outcomes of Phacoemulsification with Endoscopic Cyclophotocoagulation vs Phacoemulsification with Trabeculectomy and Mitomycin in Cataract and Glaucoma Patients.

Authors:  Medhat A Bakr; Naif K Al-Mutairi
Journal:  Clin Ophthalmol       Date:  2021-08-24

Review 7.  High-Intensity Focused Ultrasound Circular Cyclocoagulation in Glaucoma: A Step Forward for Cyclodestruction?

Authors:  Rodolfo Mastropasqua; Vincenzo Fasanella; Alessandra Mastropasqua; Marco Ciancaglini; Luca Agnifili
Journal:  J Ophthalmol       Date:  2017-04-22       Impact factor: 1.909

8.  Combined Phacoendoscopic Cyclophotocoagulation versus Combined Phacotrabeculectomy in the Management of Coexisting Cataract and Glaucoma: A Comparative Study.

Authors:  Charles Sing Lok Lau; Jeffrey Chi Wang Chan; Sophia Fei So; Orlando Chia Chieh Chan; Kenneth Kai Wang Li
Journal:  J Ophthalmol       Date:  2018-12-16       Impact factor: 1.909

9.  Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits.

Authors:  Baoke Hou; Fengxiang Wang; Zi Ye; Xin Jin; Yu Fu; Zhaohui Li
Journal:  Mol Med Rep       Date:  2019-12-31       Impact factor: 2.952

10.  Efficacy and Safety of Combined Surgeries including Intraocular Direct Cyclophotocoagulation with a 532 nm Laser to Treat Advanced Neovascular Glaucoma.

Authors:  Xiaomin Chen; Tian Zheng; Wen Zeng; Xia Fu; Shun Wang; Weijuan Zeng; Min Ke
Journal:  J Ophthalmol       Date:  2021-07-07       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.